• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    January 6, 2020


    Media Contact:

    Deidre McCabe, Director, Office of Communications, 410-767-3536

    Maureen Regan, Deputy Director, Office of Communications, 410-767-8649


    Maryland awarded federal innovation funds to address impact of the opioid crisis on maternal and child health


    Baltimore, MD – The Maryland Department of Health (MDH) has launched the Maternal Opioid Misuse (MOM) model this month, using funds from the Centers for Medicare and Medicaid Services (CMS). The MOM initiative focuses on improving care for pregnant and postpartum Medicaid participants who are diagnosed with opioid use disorder (OUD).


    “The Maryland Department of Health remains committed to ending the opioid crisis, and the MOM model is one very specific but critical approach,” said MDH Secretary Robert R. Neall. “By targeting these resources and continuing to align efforts — from the federal level to our local partners — we will increase support for women and families in seeking treatment and finding success in recovery.”


    According to CMS, substance use is a leading cause of maternal death. Because pregnant and postpartum women are more likely to be receiving health care, MOM focuses on providing additional resources to women with OUD during and after their pregnancies. The initiative strives to deliver better care from maternity and primary care to behavioral health care and substance use disorder treatment.


    Maryland is one of 10 states to secure MOM funding. The state will receive $3.6 million over the next five years to implement the initiative, with the opportunity to receive an additional $1.5 million based on performance targets. Maryland’s Medicaid program will work with CMS to develop long-term coverage and payment strategies, while working with its HealthChoice managed care organizations to improve care and service delivery to pregnant and postpartum women with OUD.


    “As we continue to combat the opioid crisis, this new funding presents a unique opportunity to improve health outcomes for one of Maryland’s most vulnerable populations,” said MDH Chief Operating Officer Dennis Schrader. “This initiative will result in bringing better health care to mothers and children at an especially critical time.”


    The new funding is a timely and strategic complement to the CDC’s Overdose Data to Action grant, which MDH’s Public Health Administration received in September 2019. The three-year cooperative agreement enables the state to leverage more timely overdose data to support increased intervention and prevention capacities.


    According to the American College of Obstetricians and Gynecologists, pregnant and postpartum women who misuse substances are at high risk for poor maternal outcomes, including preterm labor and delivery complications. The problems are frequently made worse by malnourishment, interpersonal violence and other health-related social needs.


    'The social aspects of health care play an enormous role in public health,” said Deputy Secretary for Public Health Fran Phillips. “Medicaid’s MOM initiative aligns with Public Health’s community-based opioid intervention and prevention efforts. Together, we have greater potential to help more women with opioid use disorder and their infants get better care across the state.”


    For more information about the MOM model, visit https://innovation.cms.gov/initiatives/maternal-opioid-misuse-model/.


    For more information about the Overdose Data to Action, visit https://www.cdc.gov/drugoverdose/od2a/index.html.


    For more information about Maryland’s response to the opioid crisis, visit https://beforeitstoolate.maryland.gov.




    The Maryland Department of Health is dedicated to protecting and improving the health and safety of all Marylanders through disease prevention, access to care, quality management and community engagement.


    Follow us on Twitter @MDHealthDept and at Facebook.com/MDHealthDept.​​